323 related articles for article (PubMed ID: 21872918)
1. Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial.
Mehilli J; Pache J; Abdel-Wahab M; Schulz S; Byrne RA; Tiroch K; Hausleiter J; Seyfarth M; Ott I; Ibrahim T; Fusaro M; Laugwitz KL; Massberg S; Neumann FJ; Richardt G; Schömig A; Kastrati A;
Lancet; 2011 Sep; 378(9796):1071-8. PubMed ID: 21872918
[TBL] [Abstract][Full Text] [Related]
2. Efficacy Over Time With Drug-Eluting Stents in Saphenous Vein Graft Lesions.
Colleran R; Kufner S; Mehilli J; Rosenbeiger C; Schüpke S; Hoppmann P; Joner M; Mankerious N; Fusaro M; Cassese S; Abdel-Wahab M; Neumann FJ; Richardt G; Ibrahim T; Schunkert H; Laugwitz KL; Kastrati A; Byrne RA;
J Am Coll Cardiol; 2018 May; 71(18):1973-1982. PubMed ID: 29724350
[TBL] [Abstract][Full Text] [Related]
3. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial.
Sabate M; Cequier A; Iñiguez A; Serra A; Hernandez-Antolin R; Mainar V; Valgimigli M; Tespili M; den Heijer P; Bethencourt A; Vazquez N; Gómez-Hospital JA; Baz JA; Martin-Yuste V; van Geuns RJ; Alfonso F; Bordes P; Tebaldi M; Masotti M; Silvestro A; Backx B; Brugaletta S; van Es GA; Serruys PW
Lancet; 2012 Oct; 380(9852):1482-90. PubMed ID: 22951305
[TBL] [Abstract][Full Text] [Related]
4. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.
Stettler C; Wandel S; Allemann S; Kastrati A; Morice MC; Schömig A; Pfisterer ME; Stone GW; Leon MB; de Lezo JS; Goy JJ; Park SJ; Sabaté M; Suttorp MJ; Kelbaek H; Spaulding C; Menichelli M; Vermeersch P; Dirksen MT; Cervinka P; Petronio AS; Nordmann AJ; Diem P; Meier B; Zwahlen M; Reichenbach S; Trelle S; Windecker S; Jüni P
Lancet; 2007 Sep; 370(9591):937-48. PubMed ID: 17869634
[TBL] [Abstract][Full Text] [Related]
5. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
Brilakis ES; Lichtenwalter C; Abdel-karim AR; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S
JACC Cardiovasc Interv; 2011 Feb; 4(2):176-82. PubMed ID: 21349456
[TBL] [Abstract][Full Text] [Related]
6. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial.
Kedhi E; Joesoef KS; McFadden E; Wassing J; van Mieghem C; Goedhart D; Smits PC
Lancet; 2010 Jan; 375(9710):201-9. PubMed ID: 20060578
[TBL] [Abstract][Full Text] [Related]
7. Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.
Christiansen EH; Jensen LO; Thayssen P; Tilsted HH; Krusell LR; Hansen KN; Kaltoft A; Maeng M; Kristensen SD; Bøtker HE; Terkelsen CJ; Villadsen AB; Ravkilde J; Aarøe J; Madsen M; Thuesen L; Lassen JF;
Lancet; 2013 Feb; 381(9867):661-9. PubMed ID: 23374649
[TBL] [Abstract][Full Text] [Related]
8. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.
Brodie BR; Wilson H; Stuckey T; Nussbaum M; Laurent S; Bradshaw B; Humphrey A; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Simonton CA;
JACC Cardiovasc Interv; 2009 Nov; 2(11):1105-12. PubMed ID: 19926052
[TBL] [Abstract][Full Text] [Related]
9. Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial.
Räber L; Kelbæk H; Ostojic M; Baumbach A; Heg D; Tüller D; von Birgelen C; Roffi M; Moschovitis A; Khattab AA; Wenaweser P; Bonvini R; Pedrazzini G; Kornowski R; Weber K; Trelle S; Lüscher TF; Taniwaki M; Matter CM; Meier B; Jüni P; Windecker S;
JAMA; 2012 Aug; 308(8):777-87. PubMed ID: 22910755
[TBL] [Abstract][Full Text] [Related]
10. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial.
Stone GW; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Kornowski R; Hartmann F; Gersh BJ; Pocock SJ; Dangas G; Wong SC; Fahy M; Parise H; Mehran R;
Lancet; 2011 Jun; 377(9784):2193-204. PubMed ID: 21665265
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial.
Rasmussen K; Maeng M; Kaltoft A; Thayssen P; Kelbaek H; Tilsted HH; Abildgaard U; Christiansen EH; Engstrøm T; Krusell LR; Ravkilde J; Hansen PR; Hansen KN; Abildstrøm SZ; Aarøe J; Jensen JS; Kristensen SD; Bøtker HE; Madsen M; Johnsen SP; Jensen LO; Sørensen HT; Thuesen L; Lassen JF;
Lancet; 2010 Mar; 375(9720):1090-9. PubMed ID: 20231034
[TBL] [Abstract][Full Text] [Related]
12. Drug-eluting versus bare-metal stents for saphenous vein graft lesions.
Conte SM; Florisson DS; De Bono JA; Vale PR
Intern Med J; 2019 Dec; 49(12):1534-1537. PubMed ID: 31808253
[TBL] [Abstract][Full Text] [Related]
13. Comparison of long-term outcomes of drug-eluting stents and bare metal stents for saphenous vein graft stenosis.
Chakravarty T; Morrissey RP; Wertman B; Naghi J; Chou S; Goykhman P; Doctor N; Mirocha J; Forrester JS; Makkar R
Catheter Cardiovasc Interv; 2012 May; 79(6):903-9. PubMed ID: 21805570
[TBL] [Abstract][Full Text] [Related]
14. Comparison of sirolimus-eluting stents with paclitaxel-eluting stents in saphenous vein graft intervention (from a multicenter Southern California Registry).
Lee MS; Hu PP; Aragon J; Shah AP; Oyama J; Dhoot J; Iqbal Z; Jones N; Penny W; Tobis J; Mahmud E; French W
Am J Cardiol; 2010 Aug; 106(3):337-41. PubMed ID: 20643242
[TBL] [Abstract][Full Text] [Related]
15. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial.
Byrne RA; Kastrati A; Massberg S; Wieczorek A; Laugwitz KL; Hadamitzky M; Schulz S; Pache J; Fusaro M; Hausleiter J; Schömig A; Mehilli J;
J Am Coll Cardiol; 2011 Sep; 58(13):1325-31. PubMed ID: 21920260
[TBL] [Abstract][Full Text] [Related]
17. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial.
Windecker S; Serruys PW; Wandel S; Buszman P; Trznadel S; Linke A; Lenk K; Ischinger T; Klauss V; Eberli F; Corti R; Wijns W; Morice MC; di Mario C; Davies S; van Geuns RJ; Eerdmans P; van Es GA; Meier B; Jüni P
Lancet; 2008 Sep; 372(9644):1163-73. PubMed ID: 18765162
[TBL] [Abstract][Full Text] [Related]
18. Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial.
Brilakis ES; Edson R; Bhatt DL; Goldman S; Holmes DR; Rao SV; Shunk K; Rangan BV; Mavromatis K; Ramanathan K; Bavry AA; Garcia S; Latif F; Armstrong E; Jneid H; Conner TA; Wagner T; Karacsonyi J; Uyeda L; Ventura B; Alsleben A; Lu Y; Shih MC; Banerjee S;
Lancet; 2018 May; 391(10134):1997-2007. PubMed ID: 29759512
[TBL] [Abstract][Full Text] [Related]
19. Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial.
Latif F; Uyeda L; Edson R; Bhatt DL; Goldman S; Holmes DR; Rao SV; Shunk K; Aggarwal K; Uretsky B; Bolad I; Ziada K; McFalls E; Irimpen A; Truong HT; Kinlay S; Papademetriou V; Velagaleti RS; Rangan BV; Mavromatis K; Shih MC; Banerjee S; Brilakis ES
Circ Cardiovasc Interv; 2020 Feb; 13(2):e008494. PubMed ID: 32019343
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
Stone GW; Lansky AJ; Pocock SJ; Gersh BJ; Dangas G; Wong SC; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Ochala A; Kellock A; Parise H; Mehran R;
N Engl J Med; 2009 May; 360(19):1946-59. PubMed ID: 19420364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
